[
    [
        {
            "time": "2022-11-15",
            "original_text": "The Johnson & Johnson split ‘makes sense’ as it moves into ‘more innovative products’: Analyst",
            "features": {
                "keywords": [
                    "Johnson & Johnson",
                    "split",
                    "innovative products",
                    "analyst"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "The Johnson & Johnson split ‘makes sense’ as it moves into ‘more innovative products’: Analyst",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-11-16",
            "original_text": "A (Virtual) Field Trip Into the Heart",
            "features": {
                "keywords": [
                    "virtual field trip",
                    "heart"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "education",
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "A (Virtual) Field Trip Into the Heart",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 2,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2022-11-17",
            "original_text": "Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial",
            "features": {
                "keywords": [
                    "Abbott",
                    "leadless pacemaker",
                    "primary endpoints",
                    "pivotal trial"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]